Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Barinthus Biotherapeutics plc American Depositary Shares (NASDAQ : BRNS) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Vaccitech PLC is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. Its therapeutic programs include VTP-300, VTP-200, VTP-850, and VTP-600. Its current prophylactic programs include VTP-400. In addition, it also co-invented a COVID-19 vaccine candidate with the University of Oxford known as COVID-19 Vaccine AstraZeneca.
Quote
| Last: | $0.6001 |
|---|---|
| Change Percent: | -0.97% |
| Open: | $0.6001 |
| Close: | $0.6001 |
| High: | $0.6122 |
| Low: | $0.6 |
| Volume: | 4,796 |
| Last Trade Date Time: | 07/22/2026 03:35:24 pm |
Stock Data
| Market Cap: | $28,989,551 |
|---|---|
| Float: | 36,461,505 |
| Insiders Ownership: | 0.3% |
| Institutions: | 5 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.barinthusbio.com |
| Country: | GB |
| City: | Germantown |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Barinthus Biotherapeutics plc American Depositary Shares (NASDAQ: BRNS).
